Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2794-2020Class II

Philips HeartStart MRx, Monitor/Defibrillators with model numbers M3535A, M3536A, M3536M, M3536MC, M3536M2...

Philips North America LLC / initiated 2020-07-16 / Terminated / root cause: manufacturing process

Philips North America, LLC began a recall of Philips HeartStart MRx, Monitor/Defibrillators with model numbers M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3, M3536M4, M3536M5, M3536M6, M3536M7... on . FDA classified it as Class II and gives the reason as "The therapy switch may fail, resulting in the device exhibiting the following behaviors: the device may not perform the selected function, the therapy knob may not change to the energy setting selected, or the device...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2794-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Philips North America LLC
Product
Philips HeartStart MRx, Monitor/Defibrillators with model numbers M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3, M3536M4, M3536M5, M3536M6, M3536M7, M3536M8, M3536M9 - Product Usage: is intended for use in hospital and pre-hospital settings by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac life support or defibrillation.
Product code
MKJ Automated External Defibrillators (Non-Wearable)
Reason for recall
The therapy switch may fail, resulting in the device exhibiting the following behaviors: the device may not perform the selected function, the therapy knob may not change to the energy setting selected, or the device may deliver a shock with an energy level different from the setting selected by the user. These device behaviors could result in a delay in therapy or a failure to deliver the intended therapy.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On July 16, 2020, the firm distributed an Urgent Medical Device Correction letter to all affected customers. Customers were informed of the product issue and were instructed to do the following: - The MRx is safe to use and can remain in service if the device does not exhibit any of the behaviors described in this Notice (the device may not perform the selected function, the therapy knob may not change to the energy setting selected, or the device may deliver a shock with an energy level different from the setting selected by the user.) - If an MRx device experiences a switch failure as described, contact your local Philips representative, who can arrange for a replacement of the switch at no charge. - Continue to perform the Shift and Operational Checks described in the Instructions for Use, Maintenance Chapter - To detect possible switch failures as early as possible, conduct Weekly Shock Tests (part of the Shift Check in the IFU) on a daily basis - It is not necessary to perform a Shock Test on days when an Operational Check is performed, since an Operational Check includes a Shock Test. - Keep a copy of the customer letter with each HeartStart MRx Instructions for Use. - To acknowledge receipt of this notification, please complete and fax the Customer Reply Form to the firm. If the MRx Therapy Switch fails, Philips will arrange for the replacement of the switch at no charge to the customer.
Quantity in commerce
95,212 units
Distribution
Worldwide distribution.
Product codes and lots
All devices are affected

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2794-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2794-2020Class IITerminatedVoluntary: Firm initiated